Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Liver Diseases

  Free Subscription


1 Am J Pathol
1 Biochem Biophys Res Commun
1 BMC Cancer
3 BMC Gastroenterol
8 Clin Res Hepatol Gastroenterol
1 Dig Dis Sci
1 Gastroenterology
4 Gut
1 Indian J Gastroenterol
2 J Gastroenterol Hepatol
3 J Hepatol
1 PLoS One
5 Transplant Proc

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Am J Pathol

  1. HURLEY EH, Tao J, Liu S, Krutsenko Y, et al
    Inhibition of HSF1 Signaling Decreases Hepatoblastoma Growth Via Induction of Apoptosis.
    Am J Pathol. 2022 Nov 3. pii: S0002-9440(22)00355.
    PubMed         Abstract available

    Biochem Biophys Res Commun

    The role of Stearoyl-CoA desaturase in hepatic de novo lipogenesis.
    Biochem Biophys Res Commun. 2022;633:81-83.
    PubMed         Abstract available

    BMC Cancer

  3. CHEN YH, Wang CC, Chen YY, Wang JH, et al
    Low-dose nivolumab in advanced hepatocellular carcinoma.
    BMC Cancer. 2022;22:1153.
    PubMed         Abstract available

    BMC Gastroenterol

  4. LI R, Jin C, Zhao W, Liang R, et al
    Development of a novel immune-related lncRNA prognostic signature for patients with hepatocellular carcinoma.
    BMC Gastroenterol. 2022;22:450.
    PubMed         Abstract available

  5. SEEBERG KA, Hofso D, Borgeraas H, Grimnes JO, et al
    Association between hepatic steatosis and fibrosis with measures of insulin sensitivity in patients with severe obesity and type 2 diabetes - a cross-sectional study.
    BMC Gastroenterol. 2022;22:448.
    PubMed         Abstract available

  6. ZHANG D, Li Q, Li D, Jia J, et al
    Stereotactic body radiation therapy as an effective local treatment for advanced hepatocellular carcinoma patients with inferior vena cava and right atrial tumor thrombus.
    BMC Gastroenterol. 2022;22:451.
    PubMed         Abstract available

    Clin Res Hepatol Gastroenterol

  7. LI N, Yang P, Fang J
    Transarterial chemoembolization (TACE) plus apatinib vs. TACE alone for hepatocellular carcinoma.
    Clin Res Hepatol Gastroenterol. 2022;46:102022.
    PubMed         Abstract available

  8. WASUWANICH P, Choudry H, So JM, Lowry S, et al
    Vanishing bile duct syndrome after drug-induced liver injury.
    Clin Res Hepatol Gastroenterol. 2022;46:102015.
    PubMed         Abstract available

  9. SHARMA D, Mandal P
    NAFLD: genetics and its clinical implications.
    Clin Res Hepatol Gastroenterol. 2022;46:102003.
    PubMed         Abstract available

  10. WU L, Yang J, Ke RS, Liu Y, et al
    Impact of lncRNA SOX9-AS1 overexpression on the prognosis and progression of intrahepatic cholangiocarcinoma.
    Clin Res Hepatol Gastroenterol. 2022;46:101999.
    PubMed         Abstract available

  11. ISSA Z, Gohy S, Zech F, Baldin P, et al
    Prevalence and characteristics of cystic fibrosis liver disease: a study highlighting the lack of histological diagnosis.
    Clin Res Hepatol Gastroenterol. 2022;46:101977.
    PubMed         Abstract available

  12. FANG Z, Yang H, Mao Y
    Letter to the editor: Liver transarterial chemoembolization plus sunitinib for unresectable hepatocellular carcinoma.
    Clin Res Hepatol Gastroenterol. 2022;46:101984.

  13. GUILLAUD O, Woimant F, Couchonnal E, Dumortier J, et al
    Maintenance therapy simplification using a single daily dose: A preliminary real-life feasibility study in patients with Wilson disease.
    Clin Res Hepatol Gastroenterol. 2022;46:101978.
    PubMed         Abstract available

  14. BOUZBIB C, El Mourabit H, Wendum D, Lasnier E, et al
    ATP-binding cassette transporters expression in rats with cirrhosis and hepatic encephalopathy.
    Clin Res Hepatol Gastroenterol. 2021 Aug 9:101784.
    PubMed         Abstract available

    Dig Dis Sci

  15. INOUE T, Kitano R, Ibusuki M, Sakamoto K, et al
    Endoscopic Ultrasound-Guided Hepaticogastrostomy with Antegrade Stenting Without Dilation Device Application for Malignant Distal Biliary Obstruction in Pancreatic Cancer.
    Dig Dis Sci. 2022 Nov 9. pii: 10.1007/s10620-022-07749.
    PubMed         Abstract available


  16. BRANDI G, Tovoli F, Tavolari S
    Have We Found the "Holy Grail" That May Predict Response to Immunotherapy in Hepatocellular Carcinoma?
    Gastroenterology. 2022 Nov 4. pii: S0016-5085(22)01252.


  17. BAJAJ JS, Pena-Rodriguez M, La Reau A, Phillips W, et al
    Longitudinal transkingdom gut microbial approach towards decompensation in outpatients with cirrhosis.
    Gut. 2022 Nov 7. pii: gutjnl-2022-328403. doi: 10.1136/gutjnl-2022-328403.
    PubMed         Abstract available

  18. TIAN S, Chu Y, Hu J, Ding X, et al
    Tumour-associated neutrophils secrete AGR2 to promote colorectal cancer metastasis via its receptor CD98hc-xCT.
    Gut. 2022 Jan 27. pii: gutjnl-2021-325137. doi: 10.1136/gutjnl-2021-325137.
    PubMed         Abstract available

  19. RAO J, Wang H, Ni M, Wang Z, et al
    FSTL1 promotes liver fibrosis by reprogramming macrophage function through modulating the intracellular function of PKM2.
    Gut. 2022;71:2539-2550.
    PubMed         Abstract available

  20. LATIF MU, Schmidt GE, Mercan S, Rahman R, et al
    NFATc1 signaling drives chronic ER stress responses to promote NAFLD progression.
    Gut. 2022;71:2561-2573.
    PubMed         Abstract available

    Indian J Gastroenterol

  21. KUMAR VV, Kothakota SR, Nair AK, Sasidharan M, et al
    Impact of sarcopenia on post-liver transplant morbidity and mortality in cirrhotic patients.
    Indian J Gastroenterol. 2022 Nov 7. pii: 10.1007/s12664-022-01262.
    PubMed         Abstract available

    J Gastroenterol Hepatol

  22. OUYANG R, Li H, Tan W, Wang X, et al
    Portal vein thrombosis compromises the performance of MELD and MELD-Na scores in patients with cirrhosis.
    J Gastroenterol Hepatol. 2022 Nov 7. doi: 10.1111/jgh.16053.
    PubMed         Abstract available

  23. KARAGIANNAKIS DS, Voulgaris T, Markakis G, Lakiotaki D, et al
    Spleen stiffness can predict liver decompensation and survival in patients with cirrhosis.
    J Gastroenterol Hepatol. 2022 Nov 8. doi: 10.1111/jgh.16057.
    PubMed         Abstract available

    J Hepatol

  24. TRANAH TH, Ballester MP, Carbonell-Asins JA, Jalan R, et al
    Reply to 'Ammonia and prognosis of cirrhosis: a new perspective for identifying high risk patients'.
    J Hepatol. 2022 Nov 2. pii: S0168-8278(22)03162.

  25. RATZIU V, Harrison SA, Loustaud-Ratti V, Bureau C, et al
    Hepatic and renal improvements with FXR agonist vonafexor in individuals with suspected fibrotic NASH.
    J Hepatol. 2022 Nov 2. pii: S0168-8278(22)03160.
    PubMed         Abstract available

  26. KUDO M, Finn RS, Qin S, Han KH, et al
    Overall survival and objective response in advanced unresectable hepatocellular carcinoma: A subanalysis of the REFLECT study.
    J Hepatol. 2022 Sep 20. pii: S0168-8278(22)03111.
    PubMed         Abstract available

    PLoS One

  27. LU Z, Li Y, Li AJ, Syn WK, et al
    Loss of GPR40 in LDL receptor-deficient mice exacerbates high-fat diet-induced hyperlipidemia and nonalcoholic steatohepatitis.
    PLoS One. 2022;17:e0277251.
    PubMed         Abstract available

    Transplant Proc

  28. BEKKI Y, Fenig Y, Myers B, Florman S, et al
    The Implication of Center Volumes in Donation After Circulatory Death for Liver Transplantation: Donor-Recipient Selection and Outcomes.
    Transplant Proc. 2022 Jul 20. pii: S0041-1345(22)00416.
    PubMed         Abstract available

  29. POHL J, Bischoff P, Oellinger R, Schoening W, et al
    Liver Transplantation and the Use of Metamizole to Treat Drug-induced Liver Injury.
    Transplant Proc. 2022 Aug 3. pii: S0041-1345(22)00422.
    PubMed         Abstract available

  30. NATSUDA K, Soyama A, Hara T, Matsushima H, et al
    The Efficacy of Acoustic Radiation Force Impulse Elastography for Predicting Clinical Outcomes in Living Donor Liver Transplant.
    Transplant Proc. 2022 Aug 3. pii: S0041-1345(22)00441.
    PubMed         Abstract available

  31. AKBULUT S, Isik B, Mehdi Uremis M, Dogan UG, et al
    Tissue Heavy Metals in Liver Diseases.
    Transplant Proc. 2022;54:1859-1864.
    PubMed         Abstract available

  32. DUIZENDSTRA AA, De Knegt RJ, Nagtzaam NMA, Betjes MGH, et al
    Minimal Development of Liver Fibrosis in Adult Tolerant Liver Transplant Recipients Late After Immunosuppressive Drug Weaning and Transplantation.
    Transplant Proc. 2022 Sep 11. pii: S0041-1345(22)00423.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.